GlassScriptPhysician profile
Tiberio F Lindgren
NPI 1275585424
$13,575.70
in general payments reported to CMS, 2019-2025
70 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,774 · 2020: $1,950 · 2021: $3,586 · 2022: $4,070 · 2023: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,270.87 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,218.64 | 2019-2023 | Calquence |
| E.R. Squibb & Sons, L.L.C. | $939.27 | 2019-2022 | |
| Seagen INC. | $714.02 | 2020-2023 | Tukysa |
| Novartis Pharmaceuticals Corporation | $705.43 | 2019-2022 | |
| Exelixis INC. | $587.72 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $573.84 | 2019-2023 | Imbruvica |
| Merck Sharp & Dohme LLC | $558.68 | 2019-2022 | |
| Genentech USA, INC. | $547.08 | 2019-2022 | |
| Celgene Corporation | $486.36 | 2019-2022 | |
| Eisai INC. | $377.45 | 2019-2022 | |
| Pfizer INC. | $364.66 | 2019-2022 | |
| Myovant Sciences INC. | $327.50 | 2021-2022 | |
| Abbvie INC. | $285.79 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $269.31 | 2019-2021 |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiberio Lindgren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.